Renal allograft pathology in the sensitized patient

Lynn D. Cornell

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Purpose of review: Patterns of renal allograft injury associated with alloantibody have been increasingly recognized over the past 2 decades. The use of more sensitive serum testing has brought to light the range of alloantibody-associated changes on biopsy at different time points posttransplant. There is likely to be an increasing number of patients with preformed alloantibody undergoing kidney transplantation, and so alloantibody-associated injury will become more prevalent. Recent findings: Acute antibody-mediated rejection (AMR) is a major complication in kidney transplant patients with preformed donor-specific antibody (DSA), particularly in the early posttransplant period. Acute AMR is characterized by acute tissue injury and is likely to be antibody mediated and complement mediated. A recent study showed a decreased risk of acute AMR with terminal complement pathway inhibition. Other studies have shown endothelialitis, a vascular lesion traditionally associated with acute cellular rejection, in AMR. Features of chronic AMR are common and include transplant glomerulopathy, peritubular capillary basement membrane multilamination, and accelerated arteriosclerosis. Although previously a diagnosis of humoral rejection usually required complement factor C4d deposition in the graft, we now recognize chronic features because of DSA even in the absence of C4d deposition. Summary: Acute and chronic AMR are major contributors to renal allograft dysfunction and loss. Recognition of tissue injury patterns associated with alloantibody can lead to treatment strategies in patients with DSA and can aid in interpreting biopsies in patients who are receiving new therapies.

Original languageEnglish (US)
Pages (from-to)327-336
Number of pages10
JournalCurrent Opinion in Organ Transplantation
Volume18
Issue number3
DOIs
StatePublished - Jun 2013

Fingerprint

Allografts
Pathology
Kidney
Isoantibodies
Antibodies
Wounds and Injuries
Tissue Donors
Transplants
Biopsy
Arteriosclerosis
Basement Membrane
Kidney Transplantation
Blood Vessels
Therapeutics
Serum

Keywords

  • Antibody-mediated rejection
  • Arteriosclerosis
  • Humoral rejection
  • Transplant

ASJC Scopus subject areas

  • Immunology and Allergy
  • Transplantation

Cite this

Renal allograft pathology in the sensitized patient. / Cornell, Lynn D.

In: Current Opinion in Organ Transplantation, Vol. 18, No. 3, 06.2013, p. 327-336.

Research output: Contribution to journalArticle

Cornell, Lynn D. / Renal allograft pathology in the sensitized patient. In: Current Opinion in Organ Transplantation. 2013 ; Vol. 18, No. 3. pp. 327-336.
@article{d934e60ab1a24f4e9be1802f84ff4094,
title = "Renal allograft pathology in the sensitized patient",
abstract = "Purpose of review: Patterns of renal allograft injury associated with alloantibody have been increasingly recognized over the past 2 decades. The use of more sensitive serum testing has brought to light the range of alloantibody-associated changes on biopsy at different time points posttransplant. There is likely to be an increasing number of patients with preformed alloantibody undergoing kidney transplantation, and so alloantibody-associated injury will become more prevalent. Recent findings: Acute antibody-mediated rejection (AMR) is a major complication in kidney transplant patients with preformed donor-specific antibody (DSA), particularly in the early posttransplant period. Acute AMR is characterized by acute tissue injury and is likely to be antibody mediated and complement mediated. A recent study showed a decreased risk of acute AMR with terminal complement pathway inhibition. Other studies have shown endothelialitis, a vascular lesion traditionally associated with acute cellular rejection, in AMR. Features of chronic AMR are common and include transplant glomerulopathy, peritubular capillary basement membrane multilamination, and accelerated arteriosclerosis. Although previously a diagnosis of humoral rejection usually required complement factor C4d deposition in the graft, we now recognize chronic features because of DSA even in the absence of C4d deposition. Summary: Acute and chronic AMR are major contributors to renal allograft dysfunction and loss. Recognition of tissue injury patterns associated with alloantibody can lead to treatment strategies in patients with DSA and can aid in interpreting biopsies in patients who are receiving new therapies.",
keywords = "Antibody-mediated rejection, Arteriosclerosis, Humoral rejection, Transplant",
author = "Cornell, {Lynn D.}",
year = "2013",
month = "6",
doi = "10.1097/MOT.0b013e3283614c5a",
language = "English (US)",
volume = "18",
pages = "327--336",
journal = "Current Opinion in Organ Transplantation",
issn = "1087-2418",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Renal allograft pathology in the sensitized patient

AU - Cornell, Lynn D.

PY - 2013/6

Y1 - 2013/6

N2 - Purpose of review: Patterns of renal allograft injury associated with alloantibody have been increasingly recognized over the past 2 decades. The use of more sensitive serum testing has brought to light the range of alloantibody-associated changes on biopsy at different time points posttransplant. There is likely to be an increasing number of patients with preformed alloantibody undergoing kidney transplantation, and so alloantibody-associated injury will become more prevalent. Recent findings: Acute antibody-mediated rejection (AMR) is a major complication in kidney transplant patients with preformed donor-specific antibody (DSA), particularly in the early posttransplant period. Acute AMR is characterized by acute tissue injury and is likely to be antibody mediated and complement mediated. A recent study showed a decreased risk of acute AMR with terminal complement pathway inhibition. Other studies have shown endothelialitis, a vascular lesion traditionally associated with acute cellular rejection, in AMR. Features of chronic AMR are common and include transplant glomerulopathy, peritubular capillary basement membrane multilamination, and accelerated arteriosclerosis. Although previously a diagnosis of humoral rejection usually required complement factor C4d deposition in the graft, we now recognize chronic features because of DSA even in the absence of C4d deposition. Summary: Acute and chronic AMR are major contributors to renal allograft dysfunction and loss. Recognition of tissue injury patterns associated with alloantibody can lead to treatment strategies in patients with DSA and can aid in interpreting biopsies in patients who are receiving new therapies.

AB - Purpose of review: Patterns of renal allograft injury associated with alloantibody have been increasingly recognized over the past 2 decades. The use of more sensitive serum testing has brought to light the range of alloantibody-associated changes on biopsy at different time points posttransplant. There is likely to be an increasing number of patients with preformed alloantibody undergoing kidney transplantation, and so alloantibody-associated injury will become more prevalent. Recent findings: Acute antibody-mediated rejection (AMR) is a major complication in kidney transplant patients with preformed donor-specific antibody (DSA), particularly in the early posttransplant period. Acute AMR is characterized by acute tissue injury and is likely to be antibody mediated and complement mediated. A recent study showed a decreased risk of acute AMR with terminal complement pathway inhibition. Other studies have shown endothelialitis, a vascular lesion traditionally associated with acute cellular rejection, in AMR. Features of chronic AMR are common and include transplant glomerulopathy, peritubular capillary basement membrane multilamination, and accelerated arteriosclerosis. Although previously a diagnosis of humoral rejection usually required complement factor C4d deposition in the graft, we now recognize chronic features because of DSA even in the absence of C4d deposition. Summary: Acute and chronic AMR are major contributors to renal allograft dysfunction and loss. Recognition of tissue injury patterns associated with alloantibody can lead to treatment strategies in patients with DSA and can aid in interpreting biopsies in patients who are receiving new therapies.

KW - Antibody-mediated rejection

KW - Arteriosclerosis

KW - Humoral rejection

KW - Transplant

UR - http://www.scopus.com/inward/record.url?scp=84879990107&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879990107&partnerID=8YFLogxK

U2 - 10.1097/MOT.0b013e3283614c5a

DO - 10.1097/MOT.0b013e3283614c5a

M3 - Article

VL - 18

SP - 327

EP - 336

JO - Current Opinion in Organ Transplantation

JF - Current Opinion in Organ Transplantation

SN - 1087-2418

IS - 3

ER -